Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Kidney Publisher Pubmed



Oroojalian F¹ ; Charbgoo F² ; Hashemi M³ ; Amani A^{1, 4} ; Yazdianrobati R⁵ ; Mokhtarzadeh A⁶ ; Ramezani M⁷ ; Hamblin MR^{8, 9, 10}
Source: Journal of Controlled Release Published:2020

Abstract

The application of nanotechnology in medicine has the potential to make a great impact on human health, ranging from prevention to diagnosis and treatment of disease. The kidneys are the main organ of the human urinary system, responsible for filtering the blood, and concentrating metabolic waste into urine by means of the renal glomerulus. The glomerular filtration apparatus presents a barrier against therapeutic agents based on charge and/or molecular size. Therefore, drug delivery to the kidneys faces significant difficulties resulting in treatment failure in several renal disorders. Accordingly, different strategies have recently being explored for enhancing the delivery of therapeutic agents across the filtration barrier of the glomerulus. Nanosystems with different physicochemical properties, including size, shape, surface, charge, and possessing biological features such as high cellular internalization, low cytotoxicity, controllable pharmacokinetics and biodistribution, have shown promising results for renal therapy. Different types of nanoparticles (NPs) have been used to deliver drugs to the kidney. In this review, we discuss nanotechnology-based drug delivery approaches for acute kidney injury, chronic kidney disease, renal fibrosis, renovascular hypertension and kidney cancer. © 2020 Elsevier B.V.